Literature DB >> 19763612

Splenic micronodular T-cell/histiocyte-rich large B-cell lymphoma: effect of prior corticosteroid therapy.

Elena Kan1, Itai Levy, Daniel Benharroch.   

Abstract

We report on three patients who were treated with corticosteroids only prior to the diagnosis of splenic lymphoma. Corticosteroids were administered for different conditions, at different doses, and for various periods of time. The primary diagnosis was splenic micronodular T-cell/histiocyte-rich large B-cell lymphoma in the three cases, and it was reached with variable difficulty. We suggest that the corticosteroid treatment was one of the causes for the complications in reaching a diagnosis. The morphologic appearance of the microscopic splenic nodules was the most variable feature and may possibly reflect the dose and duration of the corticosteroid therapy. However, the histopathologic changes are probably not related with Epstein-Barr virus-induced immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19763612     DOI: 10.1007/s00428-009-0830-y

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  18 in total

1.  Splenic micronodular T-cell/histiocyte-rich large B-cell lymphoma.

Authors:  Elena Kan; Itai Levy; Daniel Benharroch
Journal:  Ann Diagn Pathol       Date:  2007-09-14       Impact factor: 2.090

Review 2.  Corticosteroid drugs: their role in oncological practice.

Authors:  R M Lowenthal; K W Jestrimski
Journal:  Med J Aust       Date:  1986-01-20       Impact factor: 7.738

3.  The effects of prebiopsy corticosteroid treatment on the diagnosis of mediastinal lymphoma.

Authors:  S H Borenstein; T Gerstle; D Malkin; P Thorner; R M Filler
Journal:  J Pediatr Surg       Date:  2000-06       Impact factor: 2.545

Review 4.  Acute tumour lysis syndrome following a single-dose corticosteroid in children with acute lymphoblastic leukaemia.

Authors:  A Duzova; M Cetin; F Gümrük; S Yetgin
Journal:  Eur J Haematol       Date:  2001-06       Impact factor: 2.997

5.  Glucocorticoids induce apoptosis in human monocytes: potential role of IL-1 beta.

Authors:  M Schmidt; H G Pauels; N Lügering; A Lügering; W Domschke; T Kucharzik
Journal:  J Immunol       Date:  1999-09-15       Impact factor: 5.422

Review 6.  Glucocorticoids in T cell apoptosis and function.

Authors:  M J Herold; K G McPherson; H M Reichardt
Journal:  Cell Mol Life Sci       Date:  2006-01       Impact factor: 9.261

7.  Malignant lymphoma of the central nervous system: difficult histologic diagnosis after glucocorticoid therapy prior to biopsy.

Authors:  Y L Choi; Y L Suh; D Kim; Y H Ko; C O Sung; J I Lee
Journal:  Clin Neuropathol       Date:  2006 Jan-Feb       Impact factor: 1.368

8.  Induction of apoptosis by dexamethasone in the B cell lineage.

Authors:  K Andréau; C Lemaire; V Souvannavong; A Adam
Journal:  Immunopharmacology       Date:  1998-07

9.  Micronodular T-cell/histiocyte-rich large B-cell lymphoma of the spleen: histology, immunophenotype, and differential diagnosis.

Authors:  Ahmet Dogan; Jerome S Burke; Gaia Goteri; Richard N M Stitson; Andrew C Wotherspoon; Peter G Isaacson
Journal:  Am J Surg Pathol       Date:  2003-07       Impact factor: 6.394

10.  Induction of apoptosis by anti-cancer drugs with disparate modes of action: kinetics of cell death and changes in c-myc expression.

Authors:  A C Wood; P Elvin; J A Hickman
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

View more
  3 in total

Review 1.  Splenic Micronodular T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: The Corticosteroid Pretreatment Hypothesis.

Authors:  Benzion Samueli; Karen Nalbandyan; Daniel Benharroch; Itai Levi
Journal:  Acta Haematol       Date:  2021-11-09       Impact factor: 3.068

2.  New developments in the pathology of malignant lymphoma: a review of the literature published from August to November 2009.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2009-12-17       Impact factor: 0.196

3.  Primary splenic lymphoma: Current diagnostic trends.

Authors:  Sachin B Ingle; Chitra R Hinge Ingle
Journal:  World J Clin Cases       Date:  2016-12-16       Impact factor: 1.337

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.